Harry is a NIHR Academic Clinical Lecturer in Neurology. He completed his medical training and DPhil in Clinical Neurosciences in Oxford, before moving to Bristol to undertake his Neurology training in 2015. He took up his current position in July 2017.

Harry's research aims to develop biomarkers  that allow the diagnosis of Parkinson's disease in its earliest stages, before the onset of motor symptoms. Neurodegeneration in the substantia nigra starts many years before motor symptoms emerge and the final diagnosis of Parkinson’s can be made. Identification of patients in the early, prodromal, stage would provide insight into the earliest pathological pathways and open the door to the targeted use of novel neuroprotective agents.

To date, Harry’s work has focused on patients with REM sleep behaviour disorder (RBD). Whilst, independently a source of significant morbidity, RBD is also the strongest predictor of future risk of Parkinson’s disease. Better understanding of RBD and its link to Parkinson’s disease, may open new diagnostic and therapeutic opportunities. In 2015, Harry was awarded a Young Investigator Award from the World Association of Sleep Medicine and Parkinson Non-motor Study group for his work in the field.

Harry also works with the Stroke Research Group at the University of Bristol, exploring the role of imaging and machine learning algorithms in predicting patient outcome after mechanical thrombectomy.